Naropin

Active Ingredient(s): Ropivacaine
FDA Approved: * September 24, 1996
Pharm Company: * ASTRAZENECA
Category: Anesthetic

Ropivacaine (rINN) /ropvken/ is a local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the brand name Naropin. Contents 1 History 2 Clinical use 2.1 Contraindications 2.2 Adverse effects 2.3 Postarthroscopic glenohumeral chondrolysis 2.4 Treatment of overdose 3 References 4 External links History Ropivacaine was developed after bup... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Naropin 5 mg/ml Epidural; Infiltration; Perineural Injection, Solution

NDC: 0404-9924

Labeler:

Henry Schein, Inc.

Naropin 5 mg/ml Epidural; Infiltration; Perineural Injection, Solution

NDC: 52584-286

Labeler:

General Injectables & Vaccines, Inc

Naropin 2 mg/ml Epidural; Infiltration; Perineural Injection, Solution

NDC: 63323-285

Labeler:

App Pharmaceuticals, LLC

Naropin 5 mg/ml Epidural; Infiltration; Perineural Injection, Solution

NDC: 63323-286

Labeler:

App Pharmaceuticals, LLC

Naropin 7.5 mg/ml Epidural; Perineural Injection, Solution

NDC: 63323-287

Labeler:

App Pharmaceuticals, LLC

Naropin 10 mg/ml Epidural Injection, Solution

NDC: 63323-288

Labeler:

App Pharmaceuticals, LLC

Naropin 2 mg/ml Epidural; Infiltration Injection, Solution

NDC: 66298-2851

Labeler:

Fresenius Kabi Norge As

Naropin 2 mg/ml Epidural; Infiltration Injection, Solution

NDC: 66298-2852

Labeler:

Fresenius Kabi Norge As

Naropin 2 mg/ml Epidural; Infiltration Injection, Solution

NDC: 66298-2856

Labeler:

Fresenius Kabi Norge As

Naropin 10 mg/ml Epidural Injection, Solution

NDC: 66298-2881

Labeler:

Fresenius Kabi Norge As

More Results